(19)
(11) EP 2 010 155 A2

(12)

(88) Date of publication A3:
13.12.2007

(43) Date of publication:
07.01.2009 Bulletin 2009/02

(21) Application number: 07760728.1

(22) Date of filing: 16.04.2007
(51) International Patent Classification (IPC): 
A61K 9/16(2006.01)
 A61K 38/26(2006.01)
(86) International application number:
PCT/US2007/066728
(87) International publication number:
WO 2007/121411 (25.10.2007 Gazette 2007/43)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 14.04.2006 US 744882 P

(71) Applicant: MannKind Corporation
Valencia, CA 91355 (US)

(72) Inventors:
  • GREENE, Stephanie
    Ventura, CA 93004 (US)
  • BRANDT, David
    Valencia, CA (US)
  • GELBER, Cohava
    Manassas, VA 20109 (US)
  • KING, Mark
    Pasadena, CA 91106 (US)
  • CHEATHAM, Wayman, Wendell
    Columbia, MD 21045 (US)
  • OBERG, Keith
    Valencia, CA 91355 (US)
  • LEONE-BAY, Andrea
    Ridgefield, CT 06977 (US)
  • HOKENSON, Mark, J.
    Valencia, CA 91354 (US)
  • FARIS, Mary
    Los Angeles, CA 90077 (US)

(74) Representative: Green, Mark Charles 
Urquhart-Dykes & Lord LLP
30 Welbeck Street London W1G 8ER
30 Welbeck Street London W1G 8ER (GB)

   


(54) GLUCAGON-LIKE PEPTIDE 1(GLP-1) PHARMACEUTICAL FORMULATIONS